© 2021 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2021 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
February 24, 2015
Rintega (rindopepimut) has gained a Breakthrough Therapy Designation from the FDA to treat adult patients with glioblastoma multiforme (GBM) that test positive for the EGFR variant (EGFRvIII).
An Angel Among Nurses for Patients With Lung Cancer
Cancer’s Hidden Threat: Post-Diagnosis Anxiety
Expansion of IOA-244 Trial Fully Enrolled for Uveal Melanoma
Phenomenal Awareness and Community Perspective for Lung Cancer Screenings